Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA extends time for AstraZeneca's ticagrelor NDA
FDA extends time for AstraZeneca's ticagrelor NDA
FDA extends time for AstraZeneca's ticagrelor NDA
Submitted by
admin
on September 15, 2010 - 8:04am
Source:
Marketwatch
News Tags:
AstraZeneca
FDA
Ticagrelor
Brilinta
anti-clotting
Headline:
FDA extends time for AstraZeneca's ticagrelor NDA
Do Not Allow Advertisers to Use My Personal information
